Press conference on the safety of the COVID-19 vaccine

Head of BPOM Penny K Lukito gave a press statement regarding the safety of the COVID-19 vaccine in Jakarta, Thursday (19/11/2020). To ensure fulfillment of the requirements for the efficacy and safety of the COVID-19 vaccine, BPOM continues to oversee the implementation of clinical trials, starting from accelerating the evaluation process in the context of granting Clinical Test Protocol Approval (PPUK) to conducting inspections to ensure the implementation of clinical trials is in accordance with the approved protocols and regulations. implementation of Good Clinical Test Method (CUKB) or Good Clinical Practice. BETWEEN PHOTOS / Rivan Awal Lingga / hp.

–

Related posts:

Argentina will apply CanSino vaccines to the indigent, refugees

Bakery Processing Equipment Market Size, Key Company Profiles, Segmentation, Applications and Foreca...

The winter season has arrived and vaccines against influenza and Covid - El Sol de Acapulco

Covid-19 interstitial pneumonia: symptoms, treatment and therapy